Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 32.91
+0.72 (2.24%)
At close: Feb 10, 2026
Ansell Market Cap
Ansell has a market cap or net worth of 4.59 billion as of February 9, 2026. Its market cap has decreased by -9.49% in one year.
Market Cap
4.59B
Enterprise Value
5.48B
Revenue
3.06B
Ranking
n/a
PE Ratio
30.37
Stock Price
32.91
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.59B, a decrease of -8.18%. That is a compound annual growth rate of -0.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 4.59B | -8.05% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.01B |
| Pro Medicus | 16.47B |
| Cochlear | 16.36B |
| Sonic Healthcare | 10.88B |
| Ramsay Health Care | 8.25B |
| Telix Pharmaceuticals | 3.34B |
| Mesoblast | 2.88B |
| Regis Healthcare | 1.94B |